Programmable DNA Hydrogels with Zinc Oxide Nanoparticles and Cisplatin for Diagnosis and Treatment of Oral Squamous Cell Carcinoma
Advanced Healthcare Materials · 2025
DOI: 10.1002/adhm.202402895 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Dan Zhao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endodontics, the Affiliated Stomatological Hospital, Southwest Medical University, Luzhou, 646099, China. Hauptthemen laut MEDLINE: Zinc Oxide, Cisplatin, Hydrogels, Mouth Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Climbing Program of the Affiliated Stomatological Hospital of Southwest Medical University, Applied Basic Research Program of Southwest Medical University, Luzhou Science and Technology Program.
Abstract (Originalsprache)
This study explores the potential of DNA hydrogels as a novel approach for diagnosing and treating Oral Squamous Cell Carcinoma (OSCC). In the experiment, DNA hydrogels are synthesized and loaded with Zinc Oxide Nanoparticles (ZnO NPs) and Cisplatin. In vitro experiments evaluated drug delivery efficacy and the effect on cancer cell viability. In vivo, studies used mice models to assess the therapeutic potential and antimicrobial activity of the DNA hydrogels. Results demonstrate that DNA hydrogels significantly improve the delivery of Cisplatin to cancer cells, potentially allowing for lower drug doses and reduced side effects. The combination of Cisplatin and ZnO NPs show the most potent antibacterial effect against bacterial strains associated with OSCC. Analysis indicates that ZnO NPs within the hydrogels improve the efficacy of contrast agents, facilitating earlier and more accurate tumor diagnosis. The findings highlight that DNA hydrogels loaded with therapeutic agents can enhance drug delivery and reduce side effects, while ZnO NPs improve tumor diagnosis. DNA hydrogels may represent a promising patient‐centric approach for more effective OSCC treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endodontics, the Affiliated Stomatological Hospital, Southwest Medical University, Luzhou, 646099, China.
- Luzhou Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Luzhou, 646099, China.
- Institute of Stomatology, Southwest Medical University, Luzhou, 646000, China.
- Department of Oral and Maxillofacial Surgery, the Affiliated Stomatological Hospital, Southwest Medical University, Luzhou, 646099, China.
- School of Materials and Engineering, Ho hai university, Nanjing, 210000, China.
- Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research, Hangzhou, 310006, China.
ORCID-Profile: Xi Cheng
Förderung
- Climbing Program of the Affiliated Stomatological Hospital of Southwest Medical University
- Applied Basic Research Program of Southwest Medical University
- Luzhou Science and Technology Program
- Provincial Student Innovation and Entrepreneurship Training Program Project of Southwest Medical University
Zitieren
APA
Zhao, D., Liu, L., Wang, G. P., & Cheng, X. (2025). Programmable DNA Hydrogels with Zinc Oxide Nanoparticles and Cisplatin for Diagnosis and Treatment of Oral Squamous Cell Carcinoma. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202402895
Vancouver
Zhao D, Liu L, Wang GP, Cheng X. Programmable DNA Hydrogels with Zinc Oxide Nanoparticles and Cisplatin for Diagnosis and Treatment of Oral Squamous Cell Carcinoma. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202402895
BibTeX
@article{Zhao2025,
author = {Zhao, Dan and Liu, Lin and Wang, Gang Ping and Cheng, Xi},
title = {Programmable DNA Hydrogels with Zinc Oxide Nanoparticles and Cisplatin for Diagnosis and Treatment of Oral Squamous Cell Carcinoma},
journal = {Advanced Healthcare Materials},
year = {2025},
doi = {10.1002/adhm.202402895}
}
EUVIMED